Endocrine disruptors: part II [Libro electrónico] / editor: M. Metzler
Metzler, M [editor].
Tipo de material: Libro en línea Series Editor: New York, New York, United States: Springer-Verlag, c2002Descripción: xiv, 302 páginas : ilustraciones ; 25 centímetros.ISBN: 9783540422808 (Print); 9783540482093 (Online).Nota de acceso: Disponible para usuarios de ECOSUR con su clave de acceso Nota de bibliografía: Incluye bibliografía Número de sistema: 55784Contenidos:Mostrar Resumen:Tipo de ítem | Biblioteca actual | Colección | Signatura | Estado | Fecha de vencimiento | Código de barras |
---|---|---|---|---|---|---|
Libros | Biblioteca Electrónica Recursos en línea (RE) | Acervo General | Recurso digital | ECO400557845690 |
Incluye bibliografía
1. Estrogen and human breast cancer.. 2. The role of sex hormones in prostate cancer.. 3. Beneficial and adverse effects of dietary estrogens on the human endocrine system: clinical and epidemiological data.. 4. Mechanism-based carcinogenic risk assessment of estrogens and estrogen-like compounds.. 5. Alterations in male reproductive development: the role of endocrine disrupting chemicals.. 6. Effects of perinatal estrogen exposure on fertility and cancer in mice.. 7. Genotoxic potential of natural and synthetic endocrine active compounds.. 8. Emerging issues related to endocrine disrupting chemicals and environmental androgens and antiandrogens.. 9. Developmental and reproductive abnormalities associated with endocrine disruptors in wildlife.. 10. Endocrine disruption in the aquatic environment.. Bibliography
Disponible para usuarios de ECOSUR con su clave de acceso
The field of endocrine disruption or endocrine active compounds (EACs), which is just emerging and still controversial, is comprehensively covered by leading experts in Volume 3, Subvolumes L (Part I) and M (the present volume, Part II). The major classes of endocrine active chemicals are discussed, as well as methods for their detection and their association with health disturbances in humans and wildlife. The etiology of several of the human diseases associated with endocrine disruptors, e.g. breast and prostate cancer, decreased fertility and malformations, is still poorly understood, and the current state of knowledge is presented. Since hormonally active agents appear to have the potential of both adverse and beneficial effects, the evidence of health benefits associated with endocrine active compounds in humans is also presented. Basic chapters on the mode of action of EACs and on the etiology of the associated diseases facilitate the understanding of this complex subject for non-medical readers. eng
Disponible en línea
Disponible en formato PDF
Subscripción a ELSEVIER 26 de diciembre del 2013